Skip to Main Content

Paper Details

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade.
Clin Cancer Res
17
2022
HuProt Human Proteome Microarray, Human, Melanoma, PD-L1, Patients, ipilimumab, irAEs, melanoma, nivolumab, patients, recurrence
Author NameAffiliation
Wenke LiuNYU Grossman School of Medicine
David Feny??NYU Grossman School of Medicine
David Feny??NYU Grossman School of Medicine
  • 1 - 3

Datasets

Release 1.2